Low dose radiotherapies also can increase active T-cells in tumor microenvironment and normalize tumor blood vessels which may result from upregulation of several pro-angiogenic genes such as ANGPT2, TGFB2, FGF2 (64, 65). The gene discussed is TGFB2; the disease is neoplasm.